Therapiemanagement Frühabort

Etwa 12 % der klinisch diagnostizierten Schwangerschaften enden mit einem Frühabort. In Anlehnung an die internationale Leitlinie und die neue S2k-Leitlinie werden im Folgenden 3 Methoden zur Behandlung eines Frühaborts beschrieben. Neben der operativen Methode stehen ein abwartendes und ein medikamentöses Vorgehen zur Verfügung. Im Rahmen dieses Manuskripts werden die jeweiligen Vor- und Nachteile der Methoden erörtert.

Schlüsselwörter

Abort - Frühabort - Kürettage - medikamentöse Einleitung

• Literatur

• 1 Magnus MC, Wilcox AJ, Morken NH. et al. Role of maternal age and pregnancy history in risk of miscarriage: prospective register-based study. BMJ 2019; 364: l869
• 2 van den Berg MM, van Maarle MC, van Wely M. et al. Genetics of early miscarriage. Biochim Biophys Acta 2012; 1822: 1951-1959
• 3 Jackson T, Watkins E. Early pregnancy loss. JAAPA 2021; 34: 22-27
• 4 Dimitriadis E, Menkhorst E, Saito S. et al. Recurrent pregnancy loss. Nat Rev Dis Primers 2020; 6: 98
• 5 Coomarasamy A, Gallos ID, Papadopoulou A. et al. Sporadic miscarriage: evidence to provide effective care. Lancet 2021; 397: 1668-1674
• 6 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe e. V. (DGGG). S2k-Leitlinie Früher Schwangerschaftsverlust im 1. Trimenon. AWMF-Registernummer 015–076. 2024 Accessed May 21, 2025 at: https://register.awmf.org/de/leitlinien/detail/015-076
• 7 Farren J, Jalmbrant M, Falconieri N. et al. Posttraumatic stress, anxiety and depression following miscarriage and ectopic pregnancy: a multicenter, prospective, cohort study. Am J Obstet Gynecol 2020; 222: 367.e1-367.e22
• 8 Doubilet PM, Benson CB, Bourne T. et al. Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med 2013; 369: 1443-1451
• 9 National Institute for Health and Care Excellence (NICE). Ectopic pregnancy and miscarriage: diagnosis and initial management. NICE guideline. 2019 Accessed May 21, 2025 at: https://www.nice.org.uk/guidance/ng126
• 10 American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins – Gynecology. ACOG Practice Bulletin No. 200: early pregnancy loss. Obstet Gynecol 2018; 132: e197-e207
• 11 Ghosh J, Papadopoulou A, Devall AJ. et al. Methods for managing miscarriage: a network meta-analysis. Cochrane Database Syst Rev 2021; (06) CD012602
• 12 Luise C, Jermy K, May C. et al. Outcome of expectant management of spontaneous first trimester miscarriage: observational study. BMJ 2002; 324: 873-875
• 13 Erez O, Mastrolia SA, Tachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol 2015; 213: 452-463
• 14 Chu JJ, Devall AJ, Beeson LE. et al. Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double blind, placebo-controlled trial. Lancet 2020; 396: 770-778
• 15 Zhang J, Gilles JM, Barnhart K. et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med 2005; 353: 761-769
• 16 Nanda K, Lopez LM, Grimes DA. et al. Expectant care versus surgical treatment for miscarriage. Cochrane Database Syst Rev 2012; (03) CD003518
• 17 White K, Carroll E, Grossman D. Complications from first-trimester aspiration abortion: a systematic review of the literature. Contraception 2015; 92: 422-438
• 18 Dreisler E, Kjer JJ. Asherman’s syndrome: current perspectives on diagnosis and management. Int J Womens Health 2019; 11: 191-198
• 19 Silver RM, Branch DW. Placenta Accreta Spectrum. N Engl J Med 2018; 378: 1529-1536
• 20 Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet 2010; 376: 717-729